Lamotrigine Tablet, Orally Disintegrating
Product Images NDC 0115-9939

This is a graph displaying the failure probability percentage for a drug named Lamotrigine over the course of several weeks. The percentage starts at 100% and appears to decrease over time, but the specific numbers are not available because they are censored.*

This text seems to be a table or chart with data related to the failure probability percentage and censored TR of a substance called "LAMOTRIGINE" in a period of weeks. Therefore, it is not possible to provide a useful description as the provided text is not complete.*

This is the description of four different strengths of circular shaped tablets with off-white to white color. The tablet strength is 25 mg, 50 mg, 100 mg, and 200 mg. Each tablet is debossed with a unique code on one side and is plain on the other side. Code "1X526" debossed on 25 mg tablets, code "IX527" debossed on 50 mg tablets, code "IX528" debossed on 100 mg tablets, and code "X529" debossed on 200 mg tablets.*

This is a description of a medication called Lamotrigine in orally disintegrating tablets form. It is intended for patients who are already taking Lamotrigine and is not suitable for initial titration. Each tablet contains 25 mg of Lamotrigine USP. The manufacturing company is Patheon Inc. located in Whitby, Ontario, Canada, while it is manufactured for Amneal Pharmaceuticals LLC in Bridgewater, NJ. The recommended dosage can be obtained from the prescribing information. It is important to store the medication at room temperature and store it away from children. The package contains 30 tablets in 2 blisters, and the National Drug Code (NDC) for this drug is 0115-9939-08. The medication guide should be accompanied by the product when dispensed. The text also mentions various codes, but their meaning is not clear.*

This is a description of medication called Lamotrigine in Orally Disintegrating Tablets form. The medication is intended for the maintenance of patients already taking Lamotrigine and not for initial titration. The package contains 30 tablets in 2 blisters that contain 15 tablets each. The medication contains Phenylalanine 2.80 mg per tablet. The recommended dosage is available in prescribing information, and the medication should be stored at 20° to 25°C (68° to 77°F) in USP Controlled Room Temperature. The manufacturer of the tablet is Patheon Inc, Whitby, Canada, and manufactured for Amneal Pharmaceuticals LLC in Bridgewater, NJ, USA.*

This is a description of Lamotrigine Orally Disintegrating Tablets used for maintenance purposes for patients already taking Lamotrigine. The tablet contains Lamotrigine USP, 100 mg. Each pack contains 30 tablets in 3 blisters, with 10 tablets in each. The medication should be kept at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature] and out of reach of children. Contains Phenylalanine 5.60 mg per tablet. Manufactured for Amneal Pharmaceuticals LLC by Patheon Inc. in Whitby, Ontario, Canada.*

This is a description of a medication named "Lamotrigine" that comes in the form of orally disintegrating tablets. The pack contains 30 tablets that come in 3 blisters, each containing 10 tablets. It is manufactured by Patheon Inc. in Whitby, Ontario, Canada, and is intended for patients already taking Lamotrigine and not for initial titration. The medication should be stored at 20° to 25°C (68° to 77°F) and is only to be dispensed by a pharmacist with a separate medication guide provided. The product has a caution for Phenylketonurics as it contains Phenylalanine per tablet.*